The article discusses Lantheus Holdings, Inc.'s performance against other stocks following the Federal Reserve's decision to maintain interest rates. LNTH declined due to lower revenue guidance and disappointing earnings. The company focuses on radiopharmaceutical products and ranks as the worst performer.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing